Dr Reddys Laboratories RDY
NYSE RDY
$14.90 +0.38 (+2.62%)
At close: Nov 6, 2026 · 4:00 PM EST

Dr Reddys Laboratories (RDY) Non Operating Interest Expenses (2009 - 2026)

Updated

Dr Reddys Laboratories (RDY) posted Non Operating Interest Expenses of -$13.06 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with -$10.4 million a year earlier.

Analysis

Dr Reddys Laboratories (RDY) Non Operating Interest Expenses (2009 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Non Operating Interest Expenses at Dr Reddys Laboratories was -$48.48 million; for FY2026 (ended Mar 31, 2026), it came in at $40 million, up 21.2% from FY2025.

  • Annual Non Operating Interest Expenses has increased for four consecutive fiscal years, with a five-year compound annual growth rate of 25.2% (FY2021 to FY2026).
  • In prior fiscal years, Dr Reddys Laboratories' Non Operating Interest Expenses was $33 million in FY2025 (+57.1%), $21 million in FY2024 (+23.5%), $17 million in FY2023 (+30.8%) and $13 million in FY2022 (unchanged).
  • Quarterly Non Operating Interest Expenses has run from a low of -$15 million in fiscal Q1 2024 to a high of $2 million in fiscal Q2 2023 over five years.
  • According to Business Quant data, Non Operating Interest Expenses for the three prior fiscal quarters was -$13.26 million (Q1 2027), -$11.56 million (Q4 2026) and -$10.6 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn -
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 217.00 Mn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn -
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn -
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn -477.00 Mn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 269.00 Mn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn -
10 Dr Reddys Laboratories 12.40 Bn 11.74 Bn 472.93 Mn -13.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -13.06 Mn
Jun 30, 2026 -13.26 Mn
Mar 31, 2026 -11.56 Mn
Dec 31, 2025 -10.60 Mn
Sep 30, 2025 -10.40 Mn
Jun 30, 2025 -9.70 Mn
Mar 31, 2025 -7.58 Mn
Dec 31, 2024 -9.69 Mn
Sep 30, 2024 -9.04 Mn
Jun 30, 2024 -7.17 Mn
Mar 31, 2024 -7.14 Mn
Dec 31, 2023 -4.73 Mn
Sep 30, 2023 -4.27 Mn
Jun 30, 2023 -4.52 Mn
Mar 31, 2023 4.31 Mn
Dec 31, 2022 -5.09 Mn
Sep 30, 2022 -3.88 Mn
Jun 30, 2022 -4.50 Mn
Mar 31, 2022 -4.20 Mn
Dec 31, 2021 -2.87 Mn
API Access

Dr Reddys Laboratories Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=RDY&period=max&api_key=YOUR_API_KEY